Silex Systems Profile

USD 0.009  5.96%

Silex Systems Summary

Silex Systems Limited (SILXF) is traded on OTC Market in USA. It is located in 56 Clarence Street and employs 7 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 27.11 M. Silex Systems Limited has 170.47 M outstanding shares. SILEX SYSTEMS LTD has accumulated about 27.36 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check Silex Systems Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 0.16HorizonTargetOdds Above 0.16
65.69%30 days 0.16 33.97%
Based on normal probability distribution, the odds of Silex Systems to move above current price in 30 days from now is about 33.97% (This Silex Systems Limited probability density function shows the probability of Silex Systems Stock to fall within a particular range of prices over 30 days) .

Silex Systems Limited Risk Profiles

Key Fundamentals

Silex Systems Against Markets

Current Ratings

Silex Systems 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Silex Systems Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Silex Systems Limited researches, develops, commercializes, and licenses SILEX laser uranium enrichment technology in Australia. The company was founded in 1988 and is based in Sydney, Australia. Silex Systems operates under Semiconductors classification in USA and traded on OTC Market. more
NameSilex Systems Limited
CEOMichael GoldsworthyView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address56 Clarence Street
ExchangeOTC Market
Phone61 2 9704 8888
CurrencyUSD - US Dollar


Silex Systems Corporate Executives
Julie Ducie CFO, Company Secretary
Also please take a look at World Market Map. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.